Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akorn, a manufacturer of diagnostic and therapeutic pharmaceuticals, has appointed Jeffrey Whitnell as its interim CEO.
Subscribe to our email newsletter
Mr Whitnell will work in this capacity under the oversight of the special committee of the board of directors until a new CEO is named.
As the company has previously announced, the special committee was established to oversee the operations of the company while the search for a new CEO is underway, said Akorn.
Mr Whitnell joined Akorn in June 2004 as its vice president of finance and CFO. He was further appointed secretary and treasurer in August 2004 and was promoted to senior vice president in November 2004.